Navigation Links
ACT Announces Partnership With Gilead Sciences Inc.
Date:7/2/2009

SUNNYVALE, Calif., July 2 /PRNewswire/ -- Advanced Chemical Transport, one of the leading environmental companies in California, has announced a multi-year partnership with Gilead Sciences Inc., North America's third largest Bio-Med company.

ACT will provide Environmental services - including hazardous Materials disposal, vacuum truck services, spill response, site specific services and onsite waste management support from its corporate headquarters in Sunnyvale, CA.

ACT has experienced tremendous growth since its inception in 2000. The company has grown 400% in the last four years while retaining over 90% percent of its clientele in spite of a significant industry recession. The addition of Gilead Sciences Inc. to ACT's family of clients ensures ACT's continued growth and financial success. Walter H Singer, Founder and CEO of ACT, was quoted as saying, "The addition of Gilead Sciences Inc. is extremely gratifying and reaffirms the underlying reasons for ACT's success. Coupled with personal level service, ACT's recycling programs have allowed 94% of our clients' waste products to be recycled. Not only does the value of the contract assure our continued growth, but shows we can successfully compete with other national-sized firms."

About ACT

Advanced Chemical Transport provides environmental services including comprehensive waste management, transportation, disposal and environmental health and safety outsourcing to pharmaceutical, manufacturing and research firms. ACT is headquartered in Sunnyvale, Calif., with locations in Escondido, Merced and Los Angeles.

www.advancedchemical.net


'/>"/>
SOURCE Advanced Chemical Transport, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
2. Biocept, Inc. Announces Two New Director Appointments
3. Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
4. Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
5. SenesTech Announces New Vice President of Business Development
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2009 Results
7. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
8. Bion Announces Approval of New U.S. Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes
9. Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UKs Veterinary Laboratories Agency
10. Insmed Announces Addition to the Russell 3000(R) Index
11. BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , ... May 23, 2017 , ... Cambridge Semantics ... splash at this year’s Bio-IT World Conference and Expo in Boston May ... Lake® 4.0 solution. The Anzo Smart Data Lake is also a finalist for ...
(Date:5/22/2017)... ... May 22, 2017 , ... Baltimore biotech firm, PathSensors, announced ... community in developing and issuing recommendations to grow Maryland's biohealth industry and position ... 2023. , The recommendations are contained in a report from ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. ... 2017 at the Prince Of Wales Private Hospital. The procedure was performed on ... The patient failed conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):